Will 2009 be Consolidation Year for pharma?

With the giant union between Pfizer and Wyeth en route to being consummated, analysts are now speculating about other major mergers are to follow. Several think this could be the Year of Consolidation for pharma, including Deutsche Bank's Barbara Ryan and Credit Suisse analyst Catherine Arnold. Possibilities named by such analysts for future deals include Bristol-Myers Squibb, Biogen Idec, Schering-Plough and Amgen. FiercePharma

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.